Highly Contagious Delta Coronavirus Variant Spreading Fast In California

Angela Young

The Delta coronavirus variant is now the third-most common in California, new data show, underscoring the danger of the highly contagious strain to people who have not been vaccinated against COVID-19.

The variant makes up 14.5% of California coronavirus cases analyzed so far in June, up from 4.7% in May, when it was the fourth-most identified variant in California, according to data released by the California

Experts say the Delta variant poses a greater chance of infection for unvaccinated people if they are exposed. The variant, first identified in India, may be twice as transmissible as the conventional coronavirus strains. It has been responsible for the rise in cases recently in India, the United Kingdom and elsewhere.

But vaccinated people are well protected against infection and illness from the Delta variant. One recent study found that the

the Pfizer-BioNTech vaccine was 88% effective against symptomatic disease caused by the Delta variant and 96% protective against hospitalization.

There is no widespread scientific consensus on whether the Delta variant is more likely to cause more serious illness than other strains.Delta’s rise comes as California’s dominant strain, Alpha, first identified in the United Kingdom, may have peaked.

In May, the Alpha variant made up 58.4% of coronavirus cases that were analyzed in California. Alpha’s share fell in June, now making up 37.7% of analyzed cases — still the top variant but with a much smaller proportion.

The Gamma variant, first identified in Brazil, is also being seen more often in California. In May, the variant represented 10.1% of analyzed cases. It now makes up 21.6% of analyzed cases in the state, but Delta is still growing at a more rapid rate.

Los Angeles County, the nation’s most populous, has confirmed 123 Delta variant cases — 49 of them among residents of Palmdale and Lancaster. Fourteen cases of the Delta variant were in people from a single household.

L.A. County data suggest that vaccines are still overwhelmingly effective in protecting people against the Delta variant, as well as other known variants.

Of those 123 confirmed cases of the Delta variant in the county, 89% of them occurred among people who

were not vaccinated against COVID-19, and 2% among those who were partially vaccinated.

No one has died from the Delta variant in L.A. County.

The few fully vaccinated people who have been infected with the Delta variant “experienced relatively mild illness,” L.A. County Public Health Director Barbara Ferrer said.

Almost everyone who has died in L.A. County of COVID-19 in the last six months has been unvaccinated.

Data released by the county showed that 99.8% of COVID-19 deaths between Dec. 7 and June 7 occurred among unvaccinated people.

“If you are fully vaccinated, you have a lot of protection,” Ferrer said, adding that for the “very small numbers” of people who contracted the Delta variant despite vaccination, “they really did not have serious illness. … This is a pandemic of unvaccinated people.”

The results of outbreaks of the Delta variant elsewhere also support the vaccines’ effectiveness. In Israel, an outbreak of the Delta variant is “driven primarily by the unvaccinated,” tweeted Dr. Ashish Jha, dean of the Brown University School of Public Health.Some vaccinated people in Israel are still getting infected “because no vaccine is 100%,” Jha wrote. But the infections that are breaking through the immunity provided by the vaccines are causing mild disease.

“What’s happening in Israel is vaccines working exactly as we all expected,” Jha wrote.

In South Africa, President Cyril Ramaphosa on Sunday announced a sweeping set of new coronavirus restrictions, including curfews and school closures, as the country faces another surge in cases that threatens to outpace two previous spikes. The Delta variant, first discovered in India, appears to be driving South Africa’s new increase, Ramaphosa said.

South Africa recorded more than 15,000 new coronavirus cases Sunday, including 122 deaths, bringing its total number of fatalities to nearly 60,000.

Meanwhile, data released by California show that the percentage of the tested population who have antibodies to the coronavirus — a sign of immunity to COVID-19 — is also increasing.

Between May 16 and June 12, 85.9% of Californians who were tested for coronavirus antibodies had them — a promising sign of growing immunity, either because of immunization or past exposure to the virus. That’s up from 76.6%, calculated during a four-week period in May.

Experts have estimated that 70% to 85% of a population needs to have immunity for a region to develop “herd immunity” to COVID-19, which interrupts the sustained transmission of the virus.

Officials are continuing to urge everyone to be vaccinated against COVID-19, including people who survived a previous infection. Experts say immunity provided by the vaccination is more robust and longer-lasting than immunity from an infection

Highly contagious Delta coronavirus variant spreading fast in California

This transmission electron microscope image shows the coronavirus that causes COVID-19.

This is original content from NewsBreak’s Creator Program. Join today to publish and share your own content.

This is original content from NewsBreak’s Creator Program. Join today to publish and share your own content.

Comments / 0

Published by

HI i am a writer and editor with 5 years of experience i produce great content for newspaper books magazines and online i can get the job done

Indianapolis, IN
85 followers

More from Angela Young

Who Should Get An Antibody Test For Cov-19? Here's What Doctors's Advise

Over 18 months into the COVID-19 pandemic with three antibodies accessible in the US, it seems like everybody knows somebody—or has essentially known about somebody—who's been inoculated and determined to have the infection from there on. So it should not shock anyone that many individuals are contemplating whether their shot is as yet taking care of its work. Enter, SARS-CoV-2 neutralizer blood tests, which distinguish the contamination battling proteins that wait after your safe framework beats COVID-19, or fires up because of an immunization. In any case, can these tests really measure whether you have COVID-19 resistance? Turns out counter acting agent tests are conclusively not prescribed to decide if you're shielded from COVID-19, as per the US Food and Drug Administration (FDA). Also, specialists don't see incredible worth in these business tests recommended for different reasons (i.e., to see if you've had COVID-19). This is what you wanted to think about immunizer tests for COVID-19, and who (in the event that anybody) ought to get a counter acting agent test. Otherwise called serology tests, immunizer tests, which require a specialist's remedy, are blood tests that identify the presence of SARS-CoV-2 antibodies in the circulatory system. Antibodies are protein atoms created by the insusceptible framework when your body fends off a microorganism or goes through inoculation; they assist with guarding your body from said microbe the following time you're presented to it, and can likewise assist with decreasing the seriousness of manifestations on account of reinfection. Immune response tests are normally used to evaluate for proof of past contamination or readiness to ward off a particular infection—i.e., proof of powerful immunization—with changing levels of precision, as indicated by the Centers for Disease Control and Prevention (CDC). While antibodies can shield individuals from getting a contamination or very wiped out from that contamination, security varies by individual and illness, additionally as indicated by the CDC. Monetarily accessible tests screen for two various types of antibodies and can let you know the number of you have, as per Dr. William Schaffner, MD, educator of irresistible infection at the Vanderbilt University Medical Center in Nashville: Spike protein antibodies Imagine a COVID-19 infection is a tennis ball with key-like spikes, and the cells they taint are locks. Regularly spikes, or spike proteins, lock up with your cells to get inside and begin duplicating. Immunizations cause the body produce antibodies that glob onto the spike proteins like air pocket gum so the keys can't get in the locks. Nucleocapside antibodies These are delivered because of contamination. Nucleocapside alludes to the tennis-ball part of the infection; neucleocapside antibodies keep this space of the infection from getting into your cells. In principle, testing positive for spike protein antibodies should mean your immunization is working, and a positive nucleocapside immunizer test ought to affirm you've had COVID-19. Yet, and this is large however—the jury is out on the number of antibodies you really wanted for resistance, and how long that invulnerability may endure, as per the FDA. In addition: "We don't know whether antibodies secure against different COVID-19 strains available for use," Dr. Cheryl G. Healton, DrPH, senior member of the School of Global Public Health at New York University, tells Health. "So there's very little worth in immunizer testing." Dr. Schaffner—and most of his irresistible sickness partners—concur: "In clinical school, we're shown you ought to never do a test except if you realize how you will manage a positive or adverse outcome," he tells Health. "On account of immune response testing, the outcomes can't be deciphered, which is the reason we don't suggest it by any stretch of the imagination." In case there's one thing in a real sense each master and overseeing body concedes to, it's that counter acting agent presence ought not replace immunization or promoters among the individuals who are qualified. The uplifting news: There are tests can precisely check for current COVID-19 diseases, per the CDC—those are known as viral tests which inspect the sputum from your nose or mouth for indications of the infection. The CDC records two kinds of viral tests ordinarily used to test for COVID-19: nucleic corrosive intensification tests, or NAATs (you might know this sort of test by one of its primary sorts, the opposite record polymerase chain response, or RT-PCR test), and antigen tests. NAATs recognize the hereditary material of the infection in examples, while antigen tests distinguish the presence of antigens. "In clinical examination settings where studies utilize profoundly approved exploration conventions for most extreme precision, immune response tests can be valuable," offers Dr. Schaffner, who can't imagine an incredible use case for a financially accessible counter acting agent test. Since these tests will not conclusively tell you in the event that you have, had, could get, or could spread COVID-19, and on the grounds that a positive test could provide you with a misguided feeling of safety, specialists for the most part advise against COVID-19 tests in all conditions outside of examination labs. The main concern here: Antibody testing isn't prescribed to check and check whether your COVID-19 immunization is as yet "working," and specialists concur there's no immense worth in testing to check whether you've recently been contaminated with the infection. Nonetheless, "assuming your medical services supplier needs to realize whether you've been contaminated with COVID-19, it could be useful," says Dr. Healton. Be that as it may, think about the outcomes while taking other factors into consideration and without plans to follow up on them: "Being immune response positive is anything but a substitute for inoculation."

Read full story

Comments / 0